OTCMNSTM
Market cap473kUSD
Dec 24, Last price
0.01USD
1D
-8.80%
1Q
-75.95%
Jan 2017
-98.71%
Name
Novelstem International Corp
Chart & Performance
P/E
—
P/S
39.46
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
15.13%
Rev. gr., 5y
-54.51%
Revenues
12k
0.00%
Net income
-4m
L+446.84%
CFO
-348k
L+91.03%
Dividend
Mar 22, 20180.45 USD/sh
Earnings
Mar 31, 2025
Profile
NovelStem International Corp. focuses on developing and commercialization of diagnostic technology for cancer treatments and the potential to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was founded in 1993 and is headquartered in Boca Raton, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||
Revenues | 12 0.00% | 12 | ||
Cost of revenue | 665 | 434 | 496 | |
Unusual Expense (Income) | ||||
NOPBT | (653) | (422) | (496) | |
NOPBT Margin | ||||
Operating Taxes | 302 | 332 | 850 | |
Tax Rate | ||||
NOPAT | (956) | (755) | (1,346) | |
Net income | (4,187) 446.84% | (766) -43.38% | (1,352) 147.96% | |
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | ||||
BB yield | ||||
| Debt | ||||
Debt current | 250 | 100 | ||
Long-term debt | 3,325 | 288 | ||
Deferred revenue | ||||
Other long-term liabilities | 535 | |||
Net debt | 1,604 | (1,945) | (2,481) | |
| Cash flow | ||||
Cash from operating activities | (348) | (182) | (181) | |
CAPEX | ||||
Cash from investing activities | (250) | |||
Cash from financing activities | 645 | 180 | 100 | |
FCF | (929) | (856) | (1,261) | |
| Balance | ||||
Cash | 53 | 6 | 9 | |
Long term investments | 1,918 | 2,227 | 2,572 | |
Excess cash | 1,970 | 2,233 | 2,581 | |
Stockholders' equity | (292,659) | (288,472) | (287,706) | |
Invested Capital | 294,817 | 290,693 | 290,222 | |
ROIC | ||||
ROCE | ||||
| EV | ||||
Common stock shares outstanding | 46,881 | 46,881 | 44,260 | |
Price | 0.19 -32.93% | 0.28 77.78% | ||
Market cap | 8,804 -28.96% | 12,393 91.97% | ||
EV | 6,859 | 9,912 | ||
EBITDA | (653) | (404) | (496) | |
EV/EBITDA | ||||
Interest | 99 | 11 | 7 | |
Interest/NOPBT | ||||